Shuli Wang

Shuli Wang has extensive work experience in the field of biotechnology and pharmaceuticals. Shuli is currently employed as a Scientist, Analytical Development at iBio, Inc. Shuli'sprevious roles include working as a Sr. Research Associate at Lynntech, Inc. from 2013 to 2020, where they were involved in various projects related to breast cancer therapeutics, drug validation, and diagnostic development. Prior to that, they worked as a Principal Research Associate at Lexicon Pharmaceuticals from 2004 to 2012, focusing on high throughput screening and lead optimization. Shuli also gained experience as a Principal Research Associate at ActivX Biosciences in 2003, where they worked on protein identification and validation using mass spectrometry. Before transitioning to industry, Shuli worked as a Postdoctoral Research Fellow at the University of Calgary Department of Biological Sciences from 1994 to 1997, conducting research on transgenic growth hormone and the effects of GnRH on hepatocarcinoma and breast cancer. Throughout their career, Shuli has demonstrated skills in assay development, cell line engineering, and molecular biology techniques.

Shuli Wang has attended McMaster University, Peking Union Medical College, and Medical School Nanchang University. However, no specific information is available regarding the start or end years, degree names, or fields of study for any of these educational experiences.